Exhibit 3.1
FOURTH AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
PROGENICS PHARMACEUTICALS, INC.
FIRST: The name of the Corporation (the “Corporation”) is
Progenics Pharmaceuticals, Inc.
SECOND: The registered office of the Corporation in the State of Delaware is located at 251 Little Falls Drive, Wilmington, DE 19808, and County of New Castle. The name of its registered agent in the State of Delaware at such address isCorporation Service Company.
THIRD: The purpose of the Corporation is to engage, directly or indirectly, in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”).
FOURTH: The total authorized capital stock of the Corporation shall be 1,000 shares of common stock, $0.01 par value per share.
FIFTH: The Corporation is to have perpetual existence.
SIXTH: The business of the Corporation shall be managed under the direction of the Board of Directors of the Corporation (the “Board of Directors”) except as otherwise provided by applicable law. The number of directors of the Corporation shall be fixed from time to time by, or in the manner provided in, theBy-Laws of the Corporation (the “By-Laws”). Election of directors need not be by written ballot unless theBy-Laws shall so provide.
SEVENTH: The Board of Directors may make, alter or repeal theBy-Laws except as otherwise provided in theBy-Laws adopted by the Corporation’s stockholders.
EIGHTH: The personal liability of the directors of the Corporation is hereby eliminated to the fullest extent permitted by paragraph (7) of subsection (b) of §102 of the General Corporation Law of the State of Delaware, as the same may be amended and supplemented.